-
Sixth Annual Wear White Luncheon Raises Support and Awareness for Cancer Immunotherapy
In June, the Cancer Research Institute (CRI) held its sixth annual Wear White Luncheon at the historic… -
Why We Give: Real Stories of Hope, Loss, and the Drive to a Future #Immune2Cancer
What drives someone to fund cancer research? At the Cancer Research Institute (CRI), the answers are as… -
2025 Cancer Immunotherapy Insights + Impact Report
A Decade of Progress. A Future of Possibility. The Cancer Research Institute (CRI)’s 2025 Cancer Immunotherapy Insights… -
2025 AACR-CRI Lloyd J. Old Award: Dr. Crystal Mackall Honored for Fearlessly Confronting the “Beast” of Cancer
The Cancer Research Institute (CRI) and the American Association for Cancer Research (AACR) have awarded Dr. Crystal… -
Immunotherapy vs. Chemotherapy: What’s the Difference?
We answer common questions patients ask about how immunotherapy compares to chemotherapy, including side effects and length…
-
The Impact of Immune Monitoring for the Early Detection of Cancer
Cancer prevention and early detection are crucial in our fight against this devastating disease. While the thought… -
Early Detection Saves Lives: The Essential Cancer Screenings You Can’t Afford to Skip
Early detection and screening are some of the most powerful tools we have to help prevent cancer…. -
Celebrating Excellence: Advancing Inclusion in Cancer Immunology
This Black History Month, we proudly honor the impact of Black scientists in cancer research and immunology…. -
AI and Cancer: The Emerging Revolution
Artificial Intelligence (AI) is everywhere these days; it’s in our homes, cars, schools, workplaces, and seemingly every…
